December 11, 2024 23:43 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | INDIA bloc to knock on Supreme Court's doors over alleged EVM manipulation during Maharashtra polls | 'Babri Masjid should be rebuilt in Bengal's Murshidabad': TMC MLA Humayun Kabir sparks row | Rajnath Singh calls on Russian Prez Vladimir Putin in Moscow, discusses bilateral defence cooperation | Police to investigate conspiracy angle in Mumbai bus accident that killed 7 | Mamata Banerjee should lead INDIA bloc: Lalu Prasad Yadav | Opposition moves no-confidence motion against VP Jagdeep Dhankar in RS
Japan approves home-made Covid-19 cure for emergency use

Japan approves home-made Covid-19 cure for emergency use

Nov 24, 2022, at 06:44 pm

Tokyo/UNI: The Japanese Health Ministry has authorised the island nation's first locally made COVID-19 oral treatment, Xocova, for emergency use.

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

May 08, 2021, at 11:57 pm

New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.

After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin

After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin

Dec 08, 2020, at 04:41 am

New Delhi/IBNS:  After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.